Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Dec;18(6):585-592.
doi: 10.1080/14737167.2018.1508345. Epub 2018 Aug 24.

Guidance Toward the Implementation of Multicriteria Decision Analysis Framework in Developing Countries

Affiliations

Guidance Toward the Implementation of Multicriteria Decision Analysis Framework in Developing Countries

András Inotai et al. Expert Rev Pharmacoecon Outcomes Res. .

Abstract

Multiple Criteria Decision Analysis (MCDA) is increasingly used in health care mainly because it moves decision-making from ad hoc to an evidence-based and comprehensive process. Developing countries with more restricted financial and human research capacities, however, should consider their own methods of MCDA development and implementation. Areas covered: An MCDA framework to improve procurement decisions of off-patent pharmaceuticals was developed for developing countries and adapted to Indonesia, Kazakhstan and Vietnam during three policy workshops. Based on the experience of these workshops and one joint workshop with international experts and decision makers from multiple developing countries, general recommendations were formulated on how to implement MCDA specifically in developing countries. We provide 17 practical MCDA implementation recommendations in four major areas, including (1) MCDA objectives; (2) technical considerations of MCDA tool; (3) development and customization of MCDA tool and (4) policy implementation of MCDA in decision-making. Expert commentary: These practical MCDA recommendations for developing countries contribute to feasible, transparent, stepwise, iterative and standardized decision-making in health care.

Keywords: Decision Making; Developing Countries; Implementation Guidance; Multiple Criteria Decision Analysis; Off-patent Pharmaceuticals.

Similar articles

See all similar articles

Cited by 3 articles

MeSH terms

LinkOut - more resources

Feedback